BNP/CALL/ALCON AG/90/0.1/21.03.25 Share Price

Warrant

DE000PC7YPA1

Real-time Boerse Frankfurt Warrants 08:21:03 29/05/2024 BST
0.32 EUR -11.11% Intraday chart for BNP/CALL/ALCON AG/90/0.1/21.03.25
Current month+227.27%
1 month+176.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
29/05/24 0.32 -11.11%
28/05/24 0.36 -7.69%
27/05/24 0.39 +5.41%
24/05/24 0.37 -11.90%
23/05/24 0.42 0.00%

Real-time Boerse Frankfurt Warrants

Last update May 29, 2024 at 08:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC7YPA
ISINDE000PC7YPA1
Date issued 09/04/2024
Strike 90 CHF
Maturity 21/03/2025 (297 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.43
Lowest since issue 0.11
Spread 0.01
Spread %3.03%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.77 USD
Average target price
93.44 USD
Spread / Average Target
+5.26%
Consensus